BB-NCIPD Ltd. is a commercial company, 100% state-owned, with over 130 years of history.
BB-NCIPD Ltd. became a separate entity at the end of 2000 based on the production department of the National Center of Infectious and Parasitic Diseases that had a long history in the manufacture of biopreparations. (see Historical notes)
BB-NCIPD Ltd. belongs to the Ministry of Health of Bulgaria.
BB-NCIPD Ltd. has inherited a skilled workforce of highly qualified physicians, pharmacists, biologists, chemists, economists and supporting personnel.
The management is introducing European standards in personnel training, staff motivation and incentives, improving constantly the educational and qualification level of the employees.
The production nomenclature covers more than 600 medicines, divided in two main groups: human medicines and in-vitro diagnostic medicine products. As result of the research and development activity of the company specialists, there have been implemented new technologies meeting the highest requirements of the international standards.
Eminent specialists, having higher education and highqualified specialists with secondary special education, who are 60% of the company personnel, work in the manufacturing, control and quality assurance.
The prophylactic, medicinal diagnostic products and nutritive environments for infectious diseases control comply with the highest contemporary requirements.
The company implements the immunization program in Bulgaria successfully by its high-effective vaccines.
The vaccines and other drugs comply with the WHO and European Pharmacopoeia requirements. The production of BB-NCIPD Ltd. satisfies a large part of the country's necessity of high-quality, effective and safe medicines for treatment, prophylactics and diagnostics of infectious diseases.
The production of immunostimulators Respivax, Urostim, Calgevax and Dentavax has been developing for the past several decades, and all have proved highest efficiency and are well accepted in Bulgaria and abroad.
The bio-products of BB-NCIPD Ltd.: BCG vaccine, PPD Tuberculin, vaccines against diphtheria, tetanus and whooping-cough, immunostimulators and allergens etc. are exported in over 90 countries in the world and this export forms more than 40% of its revenues.
The production of drugs for human medicine is fulfilled by high-qualified specialists in rooms, installation and machines, which meet the Good Manufacturing Practice requirements. BB-NCIPD Ltd. holds production license No. I-65/12.02.2003, issued by the Bulgarian Drug Agency, which approves it as a manufacturer, who meets the requirements of Human Medicines and Pharmacies Act.
In the production of bioproducts by BB-NCIPD Ltd., the main attention is paid to guarantee the high quality of the final products. A system of quality control has been implemented, which meets the requirements of ISO 9001:2000 standard (Certificate Lloyd's Register QA No. 368090).
The management is introducing European standards in personnel training, staff motivation and incentives, improving constantly the educational and qualification level of the employees.
In the production of bioproducts by BB-NCIPD Ltd., the main attention is paid to guarantee the high quality of the final products. A system of quality control has been implemented, which meets the requirements of ISO 9001:2000 standard (Certificate Lloyd's Register QA No. 368090).
